Low-dose levosimendan infusions in advanced heart failure: efficacy, safety, and factors associated with outcomes.
- DOI
- 10.1007/s00392-026-02945-z
- Published
- 2026 Jun 3
- Container
- Clinical research in cardiology : official journal of the German Cardiac Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00392-026-02945-z,
title = {Low-dose levosimendan infusions in advanced heart failure: efficacy, safety, and factors associated with outcomes.},
author = {Barras N and Kikoïne J and Liaudet L and Sotiropoulos K and Regamey J and Godinho R and Hullin R and Yerly P},
year = {2026},
journal = {Clinical research in cardiology : official journal of the German Cardiac Society},
doi = {10.1007/s00392-026-02945-z},
url = {https://doi.org/10.1007/s00392-026-02945-z}
}RIS
TY - JOUR TI - Low-dose levosimendan infusions in advanced heart failure: efficacy, safety, and factors associated with outcomes. AU - Barras N AU - Kikoïne J AU - Liaudet L AU - Sotiropoulos K AU - Regamey J AU - Godinho R AU - Hullin R AU - Yerly P PY - 2026 JO - Clinical research in cardiology : official journal of the German Cardiac Society DO - 10.1007/s00392-026-02945-z UR - https://doi.org/10.1007/s00392-026-02945-z ER -
APA
N, B., J, K., L, L., K, S., J, R., R, G., R, H., & P, Y. (2026). Low-dose levosimendan infusions in advanced heart failure: efficacy, safety, and factors associated with outcomes.. Clinical research in cardiology : official journal of the German Cardiac Society. https://doi.org/10.1007/s00392-026-02945-z
Source records
- pubmed · retrieved 2026-09-26T18:04:51.011Z